Humana Inc. (NYSE:HUM) Plans $0.89 Quarterly Dividend

Humana Inc. (NYSE:HUM) announced a quarterly dividend on Thursday, August 15th, RTT News reports. Investors of record on Monday, September 30th will be paid a dividend of 0.885 per share by the insurance provider on Friday, October 25th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.11%. The ex-dividend date of this dividend is Monday, September 30th.

Humana has raised its dividend payment by an average of 12.3% annually over the last three years. Humana has a payout ratio of 17.7% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Humana to earn $19.69 per share next year, which means the company should continue to be able to cover its $3.54 annual dividend with an expected future payout ratio of 18.0%.

Humana Stock Performance

Humana stock opened at $319.52 on Friday. The stock has a market capitalization of $38.50 billion, a price-to-earnings ratio of 19.90, a P/E/G ratio of 2.44 and a beta of 0.50. Humana has a 12-month low of $298.61 and a 12-month high of $530.54. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.70. The stock has a 50-day simple moving average of $349.94 and a 200 day simple moving average of $344.48.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share for the quarter, beating analysts’ consensus estimates of $5.89 by $1.07. Humana had a net margin of 1.53% and a return on equity of 16.12%. The business had revenue of $29.54 billion for the quarter, compared to the consensus estimate of $28.52 billion. During the same period last year, the company posted $8.94 EPS. Humana’s revenue for the quarter was up 10.4% on a year-over-year basis. On average, research analysts anticipate that Humana will post 16.01 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on HUM shares. Deutsche Bank Aktiengesellschaft increased their price target on shares of Humana from $341.00 to $349.00 and gave the company a “hold” rating in a report on Friday, August 2nd. Oppenheimer boosted their price target on Humana from $370.00 to $400.00 and gave the stock an “outperform” rating in a report on Thursday, August 1st. JPMorgan Chase & Co. lifted their price target on shares of Humana from $332.00 to $396.00 and gave the stock a “neutral” rating in a report on Wednesday, August 21st. Truist Financial boosted their target price on shares of Humana from $355.00 to $400.00 and gave the company a “hold” rating in a report on Monday, July 15th. Finally, Morgan Stanley began coverage on shares of Humana in a research note on Monday, June 24th. They issued an “equal weight” rating and a $374.00 price target for the company. Thirteen equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $398.70.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.